Outcomes of combined left bundle branch area pacing with atrioventricular nodal ablation in patients with atrial fibrillation and pulmonary disease Posted on July 8th, 2024 by LEADconnection Post navigation Previous: Biotronik receives CE mark for Amvia Sky and Edge devicesNext: Staphylococcus aureus bacteraemia, cardiac implantable electronic device, extraction, and the risk of recurrent infection; a retrospective population-based cohort study
Lead EvaluAtion for Defibrillation and Reliability Trial Investigators. Global LEADR pivotal trial results. Posted on May 23rd, 2024 by Betsy Stovsky Post navigation Previous: Cardiac implantable electronic devices and bloodstream infections: management and outcomes.Next: Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)
Cardiac implantable electronic devices and bloodstream infections: management and outcomes. Posted on May 23rd, 2024 by LEADconnection Post navigation Previous: Permanent Pacemaker-Mediated Exertional Hypoxemia in a Patient With Ebstein Anomaly.Next: Lead EvaluAtion for Defibrillation and Reliability Trial Investigators. Global LEADR pivotal trial results.